WISDOMTREE TRUST MODERN TECH PLATFORMS FUND PLAT 深 沪
等待开盘 02-03 09:30:00 美东时间
30.4929
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 30.4929
- 总市值 914.79万
- 52周最高 34.9989
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.838
- 委 比 0.00%
- 总股本 30.00万
- 历史最高 49.7773
- 量 比 0
- 振 幅 0.00%
- 历史最低 19.6608
- 每 手 1
- 风险率 0.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Med crude-Urals diffs stable as February cargoes clear slowly
Med crude-Urals diffs stable as February cargoes clear slowly MOSCOW, Jan 29 (Reuters) - Urals crude differentials to dated Brent were stable on Thursday in quiet trade while February cargoes were slow to clear, traders said. India is expected to increase buying of February Urals compared to January
01-30 00:25
MORNING BID AMERICAS-Gold-plated fear
MORNING BID AMERICAS-Gold-plated fear The opinions expressed here are those of the author, a columnist for Reuters. By Mike Dolan Jan 26 - What matters in U.S. and global markets today By Mike Dolan , Editor-At-Large, Finance and Markets Gold seemed unstoppable on Monday as it topped $5,000 per ounc
01-26 19:35
BRIEF-Overall Survival Primary Endpoint Met In Corcept’S Pivotal Phase 3 ROSELLA Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer
BRIEF-Overall Survival Primary Endpoint Met In Corcept’S Pivotal Phase 3 ROSELLA Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer Jan 22 (Reuters) - Corcept Therapeutics Inc CORT.O : OVERALL SURVIVAL PRIMARY ENDPOINT MET IN CORCEPT’S PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORIL
01-22 21:19
PLATZ Co., Ltd. Reports Mixed Financial Results
PLATZ Co., Ltd. (JP:7813) has released an update. PLATZ Co., Ltd. has reported ...
2024-08-08 15:59
